A postdoctoral position is available at Sanofi R&D (Shanghai, China) About the Job: As a member of our research team within the GPCR consortium at the iHuman Institute at Shanghai Tech University, the candidate will be part of an interdisciplinary group of researchers dedicated to advancing GPCR structural biology and related science for drug discovery. The candidate will be involved in the structural and kinetic studies of GPCR proteins. The candidate will also get training in drug discovery from industry and translational academic labs. Based on project needs, there is a possibility for the candidate to perform part of the work at Sanofi global research sites in the US, France or Germany. Publication of the study results is highly encouraged. The duration of the program is 2 years.
Qualifications: - Ph.D. in structural biology, molecular biophysics, biochemistry, or a related field, for less than 3 Years - Demonstrated expertise and track record in membrane protein expression and purification - Experience in membrane protein crystallization - Experience with surface plasmon resonance and/or related technologies is of advantage - Strong communication skills in English, ability to work independently, good team player and willing to work in an interdisciplinary environment About Sanofi (http://en.sanofi.com): Sanofi Global R&D is the Research and Development organization of Sanofi, an integrated, global healthcare company focused on patient needs and engaged in the research, development, manufacturing and marketing of healthcare products. Sanofi R&D is a global organization of approximately 16,200 scientists worldwide whose everyday mission is to focus on researching new cures and new ways of treating disease around the world. Our research and development teams develop vaccines, which can save lives by the millions for children around the world, and treatments that save the lives of one patient with a very rare disease, for example. About Asia-Pacific R&D Hub (http://www.sanofi.cn/l/cn/zh/layout.jsp?scat=96417507-9C33-489A-BEFE-863169D29703) Established in Shanghai in 2014, the Sanofi Asia-Pacific R&D Hub (AP Hub) is the first to integrate capabilities in biopharmaceuticals (Sanofi Biopharma), rare diseases (Sanofi Genzyme), vaccines (Sanofi Pasteur) and animal health (Sanofi Merial) to address the region's most critical medical needs. To Apply: Please send your C.V. to lily....@sanofi.com or matthias.dre...@sanofi.com<mailto:matthias.dre...@sanofi.com> and include a list of publications and contact information of 3 references in the CV.
